Allogenic CD19-CAR-T
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Allogenic CD19-CAR-T, covering 2026-01-05 to 2026-01-05. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study of Allogenic CD19-CAR-T in the Treatment of R/R B-Cell Hematologic Malignancies [Phase 1]